Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Sr Vice President, Sales | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to buy Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2036-08-04 | Direct | 250,000 |
Reported balance
After 2026-08-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 250,000 · Balance 250,000 F1: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030 |
Filing footnotes · ownership attribution and instrument terms
F1: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:52 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantOptions to buy Common Stock · Derivative | 250,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001654954-26-007395 · section16.xml · derivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2036-08-04 F1 · derivative.exercise_date: one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030 Read SEC document |
| May 21, 2026 Filed May 21, 2026 20:15 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 5,500 | $0.11 | $577.50 |
DisclosureSEC source: 0001654954-26-005241 · form4.xml · nonDerivative · entry 3 Klass Russell Kevin · CIK 0001999774 · Sr. Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,001,000 Read SEC document |
| May 21, 2026 Filed May 21, 2026 20:15 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 11,399 | $0.11 | $1,219.69 |
DisclosureSEC source: 0001654954-26-005241 · form4.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Sr. Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,995,500 Read SEC document |
| May 21, 2026 Filed May 26, 2026 11:41 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 104,000 | $0.10 | $10,712.00 |
DisclosureSEC source: 0001654954-26-005315 · form4.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Sr. Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Indirect · spouse Disclosed balance after: 104,000 Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:15 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 200,000 | $0.11 | $21,000.00 |
DisclosureSEC source: 0001654954-26-005241 · form4.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr. Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,984,101 Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 13:17 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 150,000 | $0.10 | $14,550.00 |
DisclosureSEC source: 0001654954-25-013020 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,784,101 Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 11:06 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value. | 120,000 | $0.10 | $11,760.00 |
DisclosureSEC source: 0001654954-25-012794 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,634,101 Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 22:21 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 5,000 | $0.10 | $475.00 |
DisclosureSEC source: 0001654954-25-012783 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,514,101 Read SEC document |
| November 06, 2025 Filed Nov 7, 2025 21:46 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 253,007 | $0.08 | $20,240.56 |
DisclosureSEC source: 0001654954-25-012706 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,509,101 Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 17:58 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 745,341 | $0.04 | $29,813.64 |
DisclosureSEC source: 0001654954-25-009503 · section16.xml · nonDerivative · entry 3 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,256,094 Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 17:58 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 250,000 | $0.04 | $10,000.00 |
DisclosureSEC source: 0001654954-25-009503 · section16.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,510,753 Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 16:30 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 250,000 | $0.04 | $10,000.00 |
DisclosureSEC source: 0001654954-25-009402 · section16.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200,030 Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 16:30 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 250,000 | $0.04 | $9,500.00 |
DisclosureSEC source: 0001654954-25-009402 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,950,030 Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 17:58 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 60,723 | $0.04 | $2,428.92 |
DisclosureSEC source: 0001654954-25-009503 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,260,753 Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 16:27 UTC | Zomedica Corp. ZOMDF · Entity 6884 | PurchaseCommon Stock, without par value | 500,000 | $0.04 | $20,000.00 |
DisclosureSEC source: 0001654954-25-009400 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,700,030 Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:46 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantOptions to buy Common Stock · Derivative | 500,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001654954-25-007017 · section16.xml · derivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: One quarter (1/4) of the options vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 06/11/2029 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:36 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without $0.070 par value | 699,980 | $0.07 | $48,998.60 |
DisclosureSEC source: 0001654954-25-002954 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200,030 Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:30 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOption to buy common stock · Derivative | 200,000 | $0.00 Strike: $0.12 | $0.00 |
DisclosureSEC source: 0001654954-25-001855 · section16.xml · derivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Sr Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-02-20 F1 · derivative.exercise_date: one fourth of the options vest on the first anniversary of the grant date and 1/48 vest each month thereafter until fully vested on 2/20/2029 Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 11:11 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 289,800 | $0.12 | $35,065.80 |
DisclosureSEC source: 0001654954-24-014057 · section16.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500,050 Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 11:11 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 210,200 | $0.12 | $25,224.00 |
DisclosureSEC source: 0001654954-24-014057 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,210,250 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:32 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 299,993 | $0.16 | $46,528.91 |
DisclosureSEC source: 0001654954-24-007748 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,050 F1 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1520 to $0.1559, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:15 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 500,000 | $0.15 | $75,100.00 |
DisclosureSEC source: 0001654954-24-007663 · section16.xml · nonDerivative · entry 2 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,700,057 F2 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1485 to $0.1526, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:15 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 200,007 | $0.15 | $29,941.05 |
DisclosureSEC source: 0001654954-24-007663 · section16.xml · nonDerivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200,057 F1 · price: The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1495 to $0.1499, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 21:07 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOption to Buy Common Stock · Derivative | 2,000,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-23-014014 · section16.xml · derivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2023-11-07 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on November 7, 2023. Read SEC document |
| November 07, 2023 Filed Nov 14, 2023 21:31 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOption to Buy Common Stock · Derivative | 2,000,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001654954-23-014368 · section16.xml · derivative · entry 1 Klass Russell Kevin · CIK 0001999774 · Vice President of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2033-11-07 F2 · derivative.exercise_price: This amendment to the Form 4 filed on November 9, 2023 is being filed to correct the exercise price. An administrative rounding error was made in the initial report, and the correct exercise price is $.20 per share. F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on November 7, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.